Key Findings
Yuri Kwon, CEO of Raphas Co., Ltd., has articulated a strategy to establish the company’s microneedle technology as a global standard production platform, with a particular focus on expanding into nascent markets such as telemedicine and wearable diagnostic patches. As part of this strategic thrust, Raphas is collaborating with Murata Manufacturing to develop and mass-produce essential bio-contact components and formulations for these next-generation patches. The technology aims to enhance drug delivery efficiency and prolong the duration of action, with its application scope extending beyond traditional cosmetic uses to pharmaceutical domains like obesity and diabetes treatment, where precise, quantitative delivery of active ingredients is crucial.
Technical & Clinical Details
- Superiority of Microneedle Technology: Raphas’ microneedles are designed with minute structures that penetrate only the outermost layer of the skin (stratum corneum), delivering active ingredients efficiently and painlessly into the dermis. This circumvents traditional challenges such as injection pain and the limited permeation efficiency of transdermal patches. For diagnostic patches, microneedles can be used for biomarker sampling from interstitial fluid or integrated with sensors for continuous physiological monitoring.
- Application in Wearable Diagnostic Patches: As a diagnostic patch, microneedles serve as a platform for collecting micro-samples from body fluids (e.g., interstitial fluid) and detecting specific biomarkers (e.g., glucose levels, lactate, electrolytes, drug concentrations) in real-time. This enables non-invasive or minimally invasive, continuous health monitoring, significantly reducing the physical burden on patients.
- Collaboration with Murata Manufacturing: Murata Manufacturing is a global leader in advanced electronic component manufacturing and material technology. The collaboration with Raphas will enable the high-precision manufacturing and mass production of bio-contact components for microneedle patches, such as sensor parts and data transmission modules, thereby enhancing product reliability and market competitiveness.
- Expansion into Pharmaceutical Sector: Building on its success in cosmetic patches, Raphas aims to apply microneedle technology to drug delivery systems for pharmaceuticals, including treatments for obesity and diabetes. For biologics that are difficult to administer orally or drugs requiring sustained blood concentrations, precise and controlled delivery via microneedles offers a significant advantage. This is expected to improve patient compliance and maximize therapeutic efficacy.
Background & Industry Context
In recent years, there has been a rapid increase in demand for wearable medical devices and non-invasive/minimally invasive diagnostic and therapeutic technologies, driven by growing interest in telemedicine, personalized medicine, and preventive healthcare. The importance of home health monitoring and self-managed treatments is particularly rising, and microneedle technology is gaining attention as a promising solution to these trends. South Korea is rapidly developing in the fields of biotechnology and digital health, and the emergence of companies like Raphas is expected to enhance the international competitiveness of the domestic industry.
Strategic Significance & Outlook
Raphas aims to establish global leadership by applying its microneedle technology across various diagnostic and therapeutic fields. The collaboration with Murata Manufacturing will accelerate the establishment of mass production systems and product sophistication, playing a crucial role in the wearable diagnostic patch market. In the future, the technology is likely to evolve towards enhanced data analysis capabilities through AI integration, detection of more complex biomarkers, or the development of ‘smart patches’ that combine drug delivery and monitoring. This is expected to significantly contribute to improving patient quality of life and reducing healthcare costs.
Source: https://www.edaily.co.kr/news/read?newsId=01626246638890768&mediaCodeNo=257&OutLnkChk=Y
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime
Comments